Morgan Stanley analyst Ronald Kamdem lowered the firm’s price target on Re/Max Holdings to $7 from $9 and keeps an Underweight rating on the shares. The firm, which models continued headwinds to U.S. agent count and says litigation remains an overhang, reduced its FY25 adjusted EBITDA estimate by about 7% to $94M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMAX:
- Zillow, Redfin to weather storm as real estate commissions fall, Barron’s says
- Appeals court says DOJ can reopen antitrust probe into NAR, Bloomberg reports
- JPMorgan sees NAR settlement as negative for Anywhere, Re/Max
- National Association of Realtors confirms $418M commission settlement
- Blair sees opportunity for CoStar, Zillow from NAR settlement
